Shots:

• Novartis along with multiple pharmaceutical companies work in collaboration with the Gates Foundation to accelerate the development- manufacturing and delivery of vaccines- diagnostics and other treatments to combat COVID-19
• The collaboration will bring a range of assets- resources- and expertise required to identify effective & scalable solutions targeting the pandemic
• Fifteen pharmaceutical companies will share their molecular compound libraries with the COVID-19 Therapeutics Accelerator launched by the Gates Foundation- Wellcome- and Mastercard for screening the potential of therapies against COVID-19

Click here ­to­ read full press release/ article | Ref: Novartis | Image: BORGEN Magazine